Stanford University |
Michael Snyder |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics - Stanford |
$22,787,914 |
University of California, San Francisco |
Valerie Weaver |
Basic Biology V |
Biophysical Determinants of Early Embryonic Stem Cell Fate Specification |
$1,186,500 |
University of California, San Diego |
Dianne McKay |
Basic Biology V |
Role of intracytoplasmic pattern recognition receptors in HSC engraftment |
$615,639 |
Salk Institute for Biological Studies |
Joseph Ecker |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics - Salk |
$13,201,635 |
University of California, San Diego |
David Cheresh |
Basic Biology V |
CD61-driven stemness program in epithelial cancer |
$1,161,000 |
University of California, Irvine |
Peter Donovan |
Basic Biology V |
Non-invasive live imaging of stem cell signature metabolic states |
$516,366 |
University of California, Santa Cruz |
Joshua Stuart |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics - UCSC |
$3,999,083 |
University of California, Berkeley |
Andrew Dillin |
Basic Biology V |
A Requirement for Protein Homeostasis in the Mediation of Stem Cell Health |
$1,034,100 |
University of California, San Diego |
Miles Wilkinson |
Basic Biology V |
New Regulators of Spermatogonial Stem Cells: RHOX Homeobox Transcription Factors |
$552,811 |
University of Southern California |
Denis Evseenko |
Basic Biology V |
Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes |
$735,138 |
University of California, San Diego |
Maike Sander |
Basic Biology V |
Defining links between chromatin state and developmental competence |
$1,050,300 |
University of California, San Diego |
Wei Wang |
Basic Biology V |
Systems-level discovery of the regulatory mechanisms directing differentiation of hESC |
$1,161,000 |
University of California, San Francisco |
Jason Rock |
Conference |
Tri-Institutional Stem Cell Retreat |
$3,500 |
Stanford University |
Thomas Rando |
Conference |
Third Annual Symposium on Regenerative Rehabilitation |
$20,000 |
Human Organ Project |
Anita Caufield |
Conference |
Regenerative Medicine Foundation 2014 Conference |
$50,000 |
Stanford University |
Joseph Wu |
Conference |
Cardiovascular Regenerative Medicine Symposium |
$9,000 |
University of California, San Diego |
Thomas Kipps |
Disease Team Therapy Development III |
Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab) |
$4,179,598 |
Stanford University |
Irving Weissman |
Disease Team Therapy Development III |
Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors |
$6,505,568 |
University of California, Los Angeles |
Donald Kohn |
Disease Team Therapy Development III |
Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease |
$13,145,465 |
University of California, Davis |
Peter Belafsky |
Disease Team Therapy Development III |
Tissue Engineered Recellularized Laryngotracheal Implants |
$3,181,162 |
University of Southern California |
Mark Humayun |
Disease Team Therapy Development III |
Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration |
$16,339,827 |
University of California, Los Angeles |
Dennis Slamon |
Disease Team Therapy Development III |
A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors |
$5,683,693 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Conference |
Keystone Symposia, "Stem Cells and Reprogramming" |
$50,000 |
University of California, Davis |
Mark Yarborough |
Conference |
Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research |
$1,020 |
University of California, San Francisco |
Jeffrey Rosenfeld |
Conference |
California ALS Research Summit 2014 |
$8,563 |
Alliance Forum Foundation |
George Hara |
Conference |
2013 World Alliance Forum in San Francisco |
$3,500 |
University of California, Los Angeles |
Dana Jones |
Conference |
7th CA/HSCI Junior PI Conference: Stem Cells 2.0 |
$2,500 |
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Conference |
The Sanford Consortium for Regenerative Medicine's Scientific Symposium and the Regen Med Partnering Forum at Stem Cell Meeting on the Mesa VIII |
$35,000 |
University of California, San Francisco |
Regis Kelly |
Conference |
The Science of Staying Younger Longer |
$6,500 |
University of California, Davis |
Alice Tarantal |
Conference |
12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$8,000 |
Scripps Research Institute |
Jeanne Loring |
Conference |
World Stem Cell Summit |
$30,000 |
University of California, Los Angeles |
Gerald Lipshutz |
Early Translational IV |
Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders |
$1,801,629 |
Cedars-Sinai Medical Center |
Dan Gazit |
Early Translational IV |
Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing |
$5,121,514 |
University of California, San Diego |
Alysson Muotri |
Early Translational IV |
A drug-screening platform for autism spectrum disorders using human astrocytes |
$1,656,456 |
Gladstone Institutes, J. David |
Steven Finkbeiner |
Early Translational IV |
Development of Novel Autophagy Inducers to Block the Progression of and Treat Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases |
$2,049,053 |
The Scintillon Institute |
Stuart Lipton |
Early Translational IV |
Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke |
$1,103,185 |
Numerate, Inc. |
John Griffin |
Early Translational IV |
Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin |
$520,015 |
Sanford Burnham Prebys Medical Discovery Institute |
Stuart Lipton |
Early Translational IV |
Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke |
$1,020,815 |
Stanford University |
Michele Calos |
Early Translational IV |
Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B |
$1,876,253 |
University of California, Los Angeles |
Robert Reiter |
Early Translational IV |
Clinical Development of an N-cadherin Antibody to Target Cancer Stem Cells |
$4,075,668 |
University of California, Los Angeles |
Zack Jerome |
Early Translational IV |
Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection |
$4,925,166 |
University of California, Irvine |
Magdalene Seiler |
Early Translational IV |
Restoring vision by sheet transplants of retinal progenitors and retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs) |
$3,998,948 |
University of California, Los Angeles |
Donald Kohn |
Early Translational IV |
Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells |
$1,651,884 |
Salk Institute for Biological Studies |
Inder Verma |
Early Translational IV |
Development of a cell and gene based therapy for hemophilia |
$2,298,634 |
Human BioMolecular Research Institute |
John Cashman |
Early Translational IV |
Improving Existing Drugs for Long QT Syndrome type 3 (LQT3) by hiPSC Disease-in-Dish Model |
$6,361,369 |
Stanford University |
Julien Sage |
Conference |
3rd International RB conference |
$10,000 |
OCTANe Foundation for Innovation |
Matthew Jenusaitis |
Conference |
Orange County Summit on Regenerative Medicine (OCSRM) |
$2,500 |
University of California, San Francisco |
Peter Stock |
Conference |
IPITA 2013 - 14th World Congress of the International Pancreas and Islet transplant Association |
$10,000 |
University of California, San Diego |
Joan Heller Brown |
Conference |
International Society for Heart Research (ISHR) XX1 World Congress |
$10,000 |
University of California, San Diego |
Eric Ahrens |
Research Leadership |
Molecular Imaging for Stem Cell Science and Clinical Application |
$5,680,474 |
Sangamo BioSciences, Inc. |
Fyodor Urnov |
Strategic Partnership II |
A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells |
$2,760,540 |
Cedars-Sinai Medical Center |
Barry Stripp |
Research Leadership |
Epithelial progenitors and the stromal niche as therapeutic targets in lung disease |
$4,841,830 |
Stanford University |
Hiromitsu Nakauchi |
Research Leadership |
Generation of functional cells and organs from iPSCs |
$5,426,135 |
University of California, San Diego |
Shu Chien |
Conference |
The 14th UC Systemwide Bioengineering Symposium |
$5,000 |
University of California, Santa Cruz |
Camilla Forsberg |
Conference |
UCSC Frontiers of Stem Cells and Aging Symposium |
$24,405 |
University of California, San Diego |
John Ravits |
Conference |
Cell Therapy for amyotrophic Lateral Sclerosis (ALS) -Testing the Limits: What should we use as preclinical standards of clinical trials? |
$7,193 |
University of California, San Diego |
Joseph Gleeson |
Tissue Collection for Disease Modeling |
CIRM Tissue Collection for Neurodevelopmental Disabilities |
$830,426 |
University of California, San Francisco |
Jacquelyn Maher |
Tissue Collection for Disease Modeling |
iPSC-derived Hepatocytes as Platforms for Research in Viral Hepatitis and Non-alcoholic Steatohepatitis |
$791,680 |
University of California, San Diego |
James Brewer |
Tissue Collection for Disease Modeling |
Collection of skin biopsies to prepare fibroblasts from patients with Alzheimer's disease and cognitively healthy elderly controls |
$643,693 |
Cellular Dynamics International |
Thomas Novak |
hiPSC Derivation |
Generation and characterization of high-quality, footprint-free human induced pluripotent stem cell lines from 3,000 donors to investigate multigenic diseases |
$16,000,000 |
FUJIFILM Cellular Dynamics |
Deborah Requesens |
hPSC Repository |
The CIRM Human Pluripotent Stem Cell Biorepository – A Resource for Safe Storage and Distribution of High Quality iPSCs |
$9,942,175 |
Stanford University |
Joachim Hallmayer |
Tissue Collection for Disease Modeling |
Induced pluripotent stem cells from children with autism spectrum disorders |
$530,265 |
University of California, Los Angeles |
Brigitte Gomperts |
Tissue Collection for Disease Modeling |
Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis |
$811,231 |
Stanford University |
Joseph Wu |
Tissue Collection for Disease Modeling |
Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases |
$1,291,832 |
University of California, San Diego |
Kang Zhang |
Tissue Collection for Disease Modeling |
Generation of fibroblast cell lines in patients with common blinding eye diseases |
$1,034,425 |
University of California, Los Angeles |
Tatiana Segura |
Conference |
2013 Materials Research Society (MRS) Spring Meeting Symposium
"Design of Cell Instructive Materials" |
$4,000 |
City of Hope, Beckman Research Institute |
Fouad Kandeel |
Conference |
2013 Rachmiel Diabetes and Obesity Levine Symposium - Advances in Diabetes Research |
$27,750 |
Children's Hospital of Los Angeles |
Tracy Grikscheit |
New Faculty Physician Scientist |
The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation |
$3,146,160 |
Stanford University |
Alan Cheng |
New Faculty Physician Scientist |
Enhancing hair cell regeneration in mouse and human inner ear |
$3,088,525 |
University of California, San Diego |
Mana Parast |
New Faculty Physician Scientist |
Human pluripotent stem cell-based therapeutics for preeclampsia |
$2,974,750 |
University of California, San Francisco |
Ophir Klein |
New Faculty Physician Scientist |
Stem cell therapy for inflammatory bowel disease |
$3,019,013 |
University of California, San Francisco |
Jason Pomerantz |
New Faculty Physician Scientist |
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application |
$2,959,014 |
University of California, San Francisco |
Ann Zovein |
New Faculty Physician Scientist |
Human endothelial reprogramming for hematopoietic stem cell therapy. |
$2,197,683 |
Stanford University |
Michelle Monje |
New Faculty Physician Scientist |
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” |
$2,800,526 |
University of California, San Francisco |
Tippi MacKenzie |
New Faculty Physician Scientist |
In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies |
$2,661,742 |
Cedars-Sinai Medical Center |
Robert Baloh |
New Faculty Physician Scientist |
Human iPSC modeling and therapeutics for degenerative peripheral nerve disease |
$3,031,737 |
University of California, Los Angeles |
Reza Ardehali |
New Faculty Physician Scientist |
Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model |
$2,930,388 |
University of California, Davis |
Emanual Maverakis |
New Faculty Physician Scientist |
Tunable hydrogels for therapeutic delivery of multipotent stem cells. |
$2,771,903 |
University of California, Los Angeles |
Ali Nsair |
New Faculty Physician Scientist |
Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. |
$2,316,894 |
Children's Neurobiological Solutions (CNS) Foundation |
Alex Richmond |
Conference |
The Best Next Steps: Setting a Path for Advancing Pediatric Neurology |
$10,000 |
ViaCyte, Inc. |
Howard Foyt |
Strategic Partnership I |
Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes |
$9,475,070 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Conference |
California ALS Summit 2012 |
$6,825 |
Vitalant Research Institute |
Shibani Pati |
Conference |
Cell Therapies in Trauma and Critical Care: Barriers in Translation from Pre-clinical to Clinical Development |
$18,440 |
University of California, San Francisco |
Ophir Klein |
Conference |
Stem Cells Craniofacial Development and Disease |
$4,500 |
Sanford Consortium for Regenerative Medicine |
Lawrence Goldstein |
Conference |
The Sanford Consortium for Regenerative Medicine Symposium and the investor and Partnering Forum at Stem Cells on the Mesa |
$44,000 |
University of California, Davis |
Alice Tarantal |
Conference |
11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$16,850 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Conference |
ISSCR - Roddenberry International Symposium on Cellular reprogramming |
$43,000 |
Research for Cure |
Marilyn Smith |
Conference |
Working 2 Walk Science & Advocacy Symposium |
$22,113 |
University of California, San Diego |
Miles Wilkinson |
Basic Biology IV |
Role of the NMD RNA Decay Pathway in Maintaining the Stem-Like State |
$1,360,450 |
Gladstone Institutes, J. David |
Sheng Ding |
Basic Biology IV |
A new paradigm of lineage-specific reprogramming |
$1,568,395 |
Stanford University |
Gerald Crabtree |
Basic Biology IV |
Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch |
$1,392,150 |
University of California, Los Angeles |
Owen Witte |
Basic Biology IV |
Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells |
$1,254,960 |
University of California, San Diego |
Ananda Goldrath |
Basic Biology IV |
Mechanisms to protect hESC-derived cells from allogenic immune rejection |
$1,160,997 |
University of California, San Diego |
David Traver |
Basic Biology IV |
DECIPHERING THE INSTRUCTIONS FOR VERTEBRATE HSC SPECIFICATION AND AMPLIFICATION. |
$1,363,698 |
Stanford University |
Roel Nusse |
Basic Biology IV |
Asymmetric stem cell division oriented by a local self-renewing signal |
$1,038,600 |
Stanford University |
Michelle Monje |
Basic Biology IV |
Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain |
$1,264,248 |
University of California, San Diego |
Eugene Yeo |
Basic Biology IV |
Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration |
$1,260,360 |
Cedars-Sinai Medical Center |
Eduardo Marbán |
Basic Biology IV |
Mechanism of heart regeneration by cardiosphere-derived cells |
$1,367,604 |
University of California, San Francisco |
Barbara Panning |
Basic Biology IV |
Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming |
$1,260,037 |
University of California, Berkeley |
Robert Tjian |
Basic Biology IV |
Transcriptional regulation of pluripotency in human embryonic stem cells |
$1,220,968 |